Mankind Pharma Ltd. is set to acquire biopharma firm Bharat Serums and Vaccines for Rs 13,630 crore, in a strategic move to enhance its presence in the women’s health and fertility market segments.According to NDTV PROFIT, This acquisition will significantly expand Mankind Pharma’s portfolio and capabilities in critical health sectors. The company will purchase Bharat Serums and Vaccines Ltd. from the private equity firm Advent International, with the transaction expected to close in three to four months.
Mumbai-based Bharat Serums offers a wide range of products focusing on women’s health, oncology, and critical care, which align with Mankind Pharma’s goal of providing comprehensive healthcare solutions. The acquisition is expected to bring synergies in research and development, manufacturing, and distribution, potentially leading to innovative product offerings and improved market reach.
Goa, June 18 Suzlon has launched the S175 (5 MW), India’s tallest and most powerful…
Evian-Les-Bains (France), June 17 India and the European Union are expected to sign their long-awaited…
June 15 Legal literacy is emerging as a crucial pillar of empowerment in India, alongside…
New Delhi, June 15 India’s wholesale price inflation accelerated to 9.68 per cent in May…
